[1]
|
Changing Landscape of Cancer Vaccines—Novel Proteomics Platform for New Antigen Compositions
International Journal of Molecular Sciences,
2022
DOI:10.3390/ijms23084401
|
|
|
[2]
|
Specific humoral and cellular immune responses in cancer patients undergoing chronic immunization with a VEGF-based therapeutic vaccine
Vaccine,
2017
DOI:10.1016/j.vaccine.2017.05.020
|
|
|
[3]
|
Vesigenurtacel-L (HS-410) in the management of high-grade nonmuscle invasive bladder cancer
Future Oncology,
2016
DOI:10.2217/fon-2016-0284
|
|
|
[4]
|
Gp96-Ig/Costimulator (OX40L, ICOSL, or 4-1BBL) Combination Vaccine Improves T-cell Priming and Enhances Immunity, Memory, and Tumor Elimination
Cancer Immunology Research,
2016
DOI:10.1158/2326-6066.CIR-15-0228
|
|
|
[5]
|
New Strategies in Bladder Cancer: A Second Coming for Immunotherapy
Clinical Cancer Research,
2016
DOI:10.1158/1078-0432.CCR-15-1135
|
|
|
[6]
|
Gaining ground on a cure through synergy: combining checkpoint inhibitors with cancer vaccines
Expert Review of Clinical Immunology,
2016
DOI:10.1080/1744666X.2016.1202114
|
|
|
[7]
|
Vaccine therapy in NSCLC: a review
Lung Cancer Management,
2015
DOI:10.2217/lmt.14.43
|
|
|
[8]
|
Allogeneic tumor cell vaccines
Human Vaccines & Immunotherapeutics,
2014
DOI:10.4161/hv.26568
|
|
|
[9]
|
Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice
Blood,
2014
DOI:10.1182/blood-2013-08-520775
|
|
|
[10]
|
The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success
Immunologic Research,
2013
DOI:10.1007/s12026-013-8450-7
|
|
|